CLINICAL_TRIALS
trial_result
· 2018-12-11
Clinical Trial Update: Sex/Gender Differences in Risk and Resilience to PTSD; Implication of Oxytocin [Phase 2]
Summary
Phase 2 clinical trial assessing sex/gender differences in risk and resilience to PTSD and the role of oxytocin; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Megan Moran-Santa Maria | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2018-12-11